Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial

Abstract : Targeting of different tissues via transcutaneous (TC), intradermal (ID) and intramuscular (IM) injection has the potential to tailor the immune response to DNA vaccination. In this Phase I randomised controlled clinical trial in HIV-1 negative volunteers we investigate whether the site and mode of DNA vaccination influences the quality of the cellular immune responses. We adopted a strategy of concurrent immunization combining IM injection with either ID or TC administration. As a third arm we assessed the response to IM injection administered with electroporation (EP). The DNA plasmid encoded a MultiHIV B clade fusion protein designed to induce cellular immunity. The vaccine and regimens were well tolerated. We observed differential shaping of vaccine induced virus-specific CD4 + and CD8 + cell-mediated immune responses. DNA given by IM + EP promoted strong IFN-γ responses and potent viral inhibition. ID + IM without EP resulted in a similar pattern of response but of lower magnitude. By contrast TC + IM (without EP) shifted responses towards a more Th-17 dominated phenotype, associated with mucosal and epidermal protection. Whilst preliminary, these results offer new perspectives for differential shaping of desired cellular immunity required to fight the wide range of complex and diverse infectious diseases and cancers.
Type de document :
Article dans une revue
Scientific Reports, Nature Publishing Group, 2017, 7, pp.13011. 〈10.1038/s41598-017-13331-1〉
Liste complète des métadonnées

Littérature citée [50 références]  Voir  Masquer  Télécharger

https://hal.sorbonne-universite.fr/hal-01627937
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : jeudi 2 novembre 2017 - 15:55:40
Dernière modification le : vendredi 31 août 2018 - 09:03:56
Document(s) archivé(s) le : samedi 3 février 2018 - 13:40:36

Fichier

s41598-017-13331-1.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

G. Haidari, Alethea Cope, A. Miller, S. Venables, C. Yan, et al.. Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial. Scientific Reports, Nature Publishing Group, 2017, 7, pp.13011. 〈10.1038/s41598-017-13331-1〉. 〈hal-01627937〉

Partager

Métriques

Consultations de la notice

298

Téléchargements de fichiers

15